Cargando…
The Evolution and Future of Targeted Cancer Therapy: From Nanoparticles, Oncolytic Viruses, and Oncolytic Bacteria to the Treatment of Solid Tumors
While many classes of chemotherapeutic agents exist to treat solid tumors, few can generate a lasting response without substantial off-target toxicity despite significant scientific advancements and investments. In this review, the paths of development for nanoparticles, oncolytic viruses, and oncol...
Autores principales: | Pierce, Kyle M., Miklavcic, William R., Cook, Kyle P., Hennen, Mikayla Sweitzer, Bayles, Kenneth W., Hollingsworth, Michael A., Brooks, Amanda E., Pullan, Jessica E., Dailey, Kaitlin M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623458/ https://www.ncbi.nlm.nih.gov/pubmed/34835785 http://dx.doi.org/10.3390/nano11113018 |
Ejemplares similares
-
Hacking the Immune Response to Solid Tumors: Harnessing the Anti-Cancer Capacities of Oncolytic Bacteria
por: Roe, Jason M., et al.
Publicado: (2023) -
Methods and Techniques to Facilitate the Development of Clostridium novyi NT as an Effective, Therapeutic Oncolytic Bacteria
por: Dailey, Kaitlin M., et al.
Publicado: (2021) -
Oncolytic Viruses in the Treatment of Bladder Cancer
por: Potts, Kyle G., et al.
Publicado: (2012) -
Oncolytic Viruses Partner With T-Cell Therapy for Solid Tumor Treatment
por: Rosewell Shaw, Amanda, et al.
Publicado: (2018) -
Past, Present and Future of Oncolytic Reovirus
por: Müller, Louise, et al.
Publicado: (2020)